AstraZeneca PLC closed 21.54% below its 52-week high of £133.88, which the company reached on September 3rd.

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents ...

AstraZeneca has announced positive high-level results from its Phase III KALOS and LOGOS trials, showing significant promise ...

The biggest strategic highlight for Tempus AI Inc. (NASDAQ: TEM) during the first quarter was a multi-million dollar deal to build "the world's largest foundation model for oncology." ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer.

Maria joined AstraZeneca in 2017 as head of Respiratory, Inflammation & Autoimmunity in the Innovative Medicines and Early Development (IMED) Biotech Unit. In her role she leads early-stage ...

If there’s one thing worse than having to assemble a PowerPoint presentation, it’s being forced to sit through an achingly dull one conducted by someone else. So what if there were a better ...

Visit a quote page and your recently viewed tickers will be displayed here.

AstraZeneca said the trial showed that Enhertu, which was jointly developed and commercialised with Daiichi Sankyo, demonstrated a "statistically significant and clinically meaningful" improvement ...

Sustainability data is currently not available for AZN.

At close: May 9 at 5:15:00 PM GMT+1 ...

Are you curious about what makes a cosmetic logo tick? Look no further! In the beauty industry, which is competitive today, having an iconic and memorable logo is very important. It often catches a ...